We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

226 hedge funds and large institutions have $1.92B invested in Arena Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 81 increasing their positions, 71 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 71

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2% less capital invested

Capital invested by funds: $1.96B → $1.92B (-$39.1M)

6% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 32

2% less funds holding

Funds holding: 230 → 226 (-4)

36% less call options, than puts

Call options by funds: $18.9M | Put options by funds: $29.3M

Holders
226
Holders Change
-4
Holders Change %
-1.74%
% of All Funds
4.45%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
30
Increased
81
Reduced
71
Closed
32
Calls
$18.9M
Puts
$29.3M
Net Calls
-$10.4M
Net Calls Change
-$5.68M

Top Buyers

1
PAM
Panagora Asset Management
Massachusetts
+$10.5M
2
Man Group
Man Group
United Kingdom
+$9.84M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.09M
4
PM
Prosight Management
Texas
+$7.8M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$7.36M

Top Sellers

1
PHS
PFM Health Sciences
California
-$56.8M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$13.6M
3
EA
Emerald Advisers
Pennsylvania
-$13.2M
4
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
-$12.9M
5
State Street
State Street
Massachusetts
-$8.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWNA
26
Marshall Wace North America
New York
$16.4M +$4.98M +105,318 +41%
Charles Schwab
27
Charles Schwab
California
$16M +$36.2K +766 +0.2%
VOYA Investment Management
28
VOYA Investment Management
Georgia
$15M -$3.85M -81,438 -20%
PM
29
Prosight Management
Texas
$14.9M +$7.8M +164,996 +101%
Point72 Asset Management
30
Point72 Asset Management
Connecticut
$14.8M +$8.09M +171,144 +111%
EMG
31
ETF Managers Group
New Jersey
$14.5M +$2.78M +58,729 +22%
APG Asset Management
32
APG Asset Management
Netherlands
$13.5M +$5.26M +111,373 +50%
PAM
33
Panagora Asset Management
Massachusetts
$13.4M +$10.5M +222,566 +306%
Wells Fargo
34
Wells Fargo
California
$13.1M -$616K -13,033 -4%
American Century Companies
35
American Century Companies
Missouri
$11.3M +$1.25M +26,441 +12%
Marshall Wace
36
Marshall Wace
United Kingdom
$10.4M -$1.08M -22,745 -9%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$10.2M +$388K +8,199 +4%
Millennium Management
38
Millennium Management
New York
$10M +$6.43M +135,946 +162%
RPAM
39
Rhenman & Partners Asset Management
Sweden
$9.99M +$3.07M +65,000 +42%
Axa
40
Axa
France
$9.8M +$236K +4,984 +2%
Deutsche Bank
41
Deutsche Bank
Germany
$9.73M +$1.46M +30,978 +17%
Bank of America
42
Bank of America
North Carolina
$9.54M +$5.07M +107,158 +104%
Adage Capital Partners
43
Adage Capital Partners
Massachusetts
$8.63M – – –
FLAM
44
First Light Asset Management
Minnesota
$8.44M -$242K -5,110 -3%
CAM
45
Cormorant Asset Management
Massachusetts
$7.83M – – –
Capital Fund Management (CFM)
46
Capital Fund Management (CFM)
France
$7.75M +$3.62M +76,601 +82%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$7.49M -$573K -12,127 -7%
JP Morgan Chase
48
JP Morgan Chase
New York
$7.46M +$1.68M +35,446 +28%
ACM
49
Atika Capital Management
New York
$7.36M -$898K -19,000 -10%
Arrowstreet Capital
50
Arrowstreet Capital
Massachusetts
$7.07M +$7.36M +155,628 New
1
2
3 4 5

ARNA Hedge Fund Activity: Q4 2019 in Review

226 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q4 2019, worth a combined $1.92B — down 2% from $1.96B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of ARNA and 30 opened new positions — a net loss of 2 holders — while 71 trimmed existing stakes and 81 added.

The largest buyer was Panagora Asset Management, adding an estimated $10.5M. The largest seller was PFM Health Sciences, cutting an estimated $56.8M.

  • 226 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q4 2019, down from 230 in Q3 2019.
  • Funds reported $1.92B of Arena Pharmaceuticals Inc stock for Q4 2019, down 2% quarter-over-quarter.
  • 30 funds opened new Arena Pharmaceuticals Inc positions in Q4 2019 and 32 closed out, a net change of -2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q4 2019 was Panagora Asset Management, an estimated $10.5M added.
  • The largest Arena Pharmaceuticals Inc seller in Q4 2019 was PFM Health Sciences, an estimated $56.8M sold.

Based on aggregated 13F filings for Q4 2019.